Hansen Medical to Present at Upcoming Investor Conferences
13 5월 2008 - 6:02AM
Marketwired
MOUNTAIN VIEW, CA , a developer of new generation robotic
technology for accurate and stable control of catheter movement in
3D during cardiac procedures, announced today that it will be
participating in upcoming investor conferences.
The company will be presenting at the JMP Securities Seventh
Annual Research Conference being held May 19-21, 2008 at The
Ritz-Carlton, San Francisco. President and Chief Operating Officer,
Gary Restani, will provide a general company overview on Monday,
May 19, 2008 at 1:30 p.m. PDT.
The company will also be presenting at the Citi Investment
Research Global Healthcare Conference being held May 21-22, 2008 at
The Hilton New York. Co-Founder and Chief Executive Officer, Fred
Moll, M.D., will provide a general company overview on Wednesday,
May 21, 2008 at 9:30 a.m. EDT.
Hansen Medical will provide live audio webcasts of each
presentation. Interested parties may access the live webcasts by
visiting the investor relations section of Hansen Medical's web
site at www.hansenmedical.com. A replay of the webcasts will be
available at the site after the live presentation.
About Hansen Medical, Inc.
Hansen Medical, Inc., based in Mountain View, Calif., develops
products and technology using robotics for the accurate
positioning, manipulation and control of catheters and
catheter-based technologies. Its first product, the Sensei Robotic
Catheter system, is a robotic navigation system that enables
clinicians to place mapping catheters in hard-to-reach anatomical
locations within the heart easily, accurately and with stability
during complex cardiac arrhythmia procedures. The Sensei system is
compatible with fluoroscopy, ultrasound, 3D surface map and patient
electrocardiogram data and was cleared by the U.S. Food &
Administration (FDA) in May 2007 for manipulation and control of
certain mapping catheters in Electrophysiology (EP) procedures. In
the European Union, the Sensei system is cleared for use during EP
procedures, such as guiding catheters in the treatment of atrial
fibrillation (AF).
The safety and effectiveness of the Sensei system for use with
cardiac ablation catheters in the treatment of cardiac arrhythmias,
including AF, have not been established. Additional information can
be found at www.hansenmedical.com.
Media Contact: Amy Cook 925.552.7893 Email Contact Investor
Contacts: Steven Van Dick 650.404.5800 Email Contact At the
Financial Relations Board: Lasse Glassen 213.486.6546 Email
Contact
Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024